the aid library

LIST OPTIONS

Filter

5579

Sort by:

Direction:

Download (2047)

View PDF (2034)

Environmental Health Management After Natural Disaster
recommended

Ruth Newman, Richard Hansen, John Quigley and Don Schramm Pan American Health Organization (2003) C_WHO

Natural disasters often increase morbidity and mortality rates. Taking appropriate measures to maintain environmental health helps to reduce or eliminate the risks of preventable disease and death. Such measures contribute not only to the health of individuals in and near disaster-stricken areas, bu... more

Download (224)

View PDF (470)

Eliminating malaria in the Greater Mekong Subregion: United to end a deadly disease

World Health Organization (WHO) (2016) C_WHO

Recent efforts to fight malaria in the Greater Mekong Subregion (GMS) have yielded impressive results. According to the latest WHO estimates, the six GMS countries cut their malaria case incidence by an estimated 54% between 2012 and 2015. Malaria death rates fell by 84% over the same period.
I... more

Download (77)

View PDF (606)

How Twitter therapists are helping bring mental health care to Nigeria

Oluwatosin Adeshokan (2019) C2

DM for Care In northeastern Nigeria—“Boko Haram’s den”—at least 3 in 10 people suffer from untreated mental illness. Despite high suicide rates and risks of radicalization, care is reserved for treating substance use or disorders like schizophrenia. Nonprofits like NEEM Foundation a... more

Download (169)

View PDF (353)

Noncommunicable diseases in the Region of the Americas: facts and figures

Pan American Health Organization (PAHO) (2019) C_WHO

This booklet presents data on NCD mortality and prevalence of NCD risk factors, by country, for the Region of the Americas. The focus is on the 5 x 5 NCD agenda which includes the main NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases), and mental health (suicide); as... more

Download (253)

View PDF (1074)

Injury Prevention and Environmental Health. Disease Control Priorities, Third Edition : Volume 7

Mock, Charles N.; Nugent, Rachel; Kobusingye, Olive; et al. World Bank (2017) CC

The substantial burden of death and disability that results from interpersonal violence, road traffic injuries, unintentional injuries, occupational health risks, air pollution, climate change, and inadequate water and sanitation falls disproportionally on low- and middle-income countries. Injury Pr... more

Download (432)

View PDF (833)

State of Health in the WHO African Region
recommended

World Health Organization WHO, Regional Office African Region (2018) C_WHO

This report is not a country scorecard. Rather, its purpose is to act as a compass to guide progress towards health in the SDGs. There has been a significant improvement in the state of health in the region with healthy life expectancy - time spent in full health - in the region increasing from 50... more

Download (206)

View PDF (425)

Lesotho: NON COMMUNICABLE DISEASES

World Health Organization (WHO) (2014) C_WHO

Download (61)

View PDF (77)

Mitigating the impact of COVID-19 on countries affected by HIV, tuberculosis and malaria

Global fund (2020) CC

While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate.... more

Download (166)

View PDF (236)

Violence and injuries in Europe: burden, prevention and priorities for action

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

The WHO Global Health Estimates show that nearly half a million deaths (493 471) occurred in the WHO European Region due to violence and injuries in 2016. This represents a decline of 29% from 2000. Injuries account for 5.3% of all deaths and 9.6 of all years of life lost. They are a leading cause o... more

Download (56)

View PDF (80)

Dietary salt intake survey in the Republic of Moldova, 2016

World Health OrganizationEurope (2018) C_WHO

High salt consumption is an important determinant of high blood pressure and reducing it would improve health outcomes by lowering cardiovascular disease and therefore death rates. Reducing salt intake has been identified as one of the most effective public health measures and is one of the leading ... more

Download (85)

View PDF (113)

Disease Control Priorities, Third Edition : Volume 7. Injury Prevention and Environmental Health

Mock C. N., Nugent R. et. al. (2017) C2

Download (50)

View PDF (271)

Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation–Lancet Commission on planetary health | Sustainable Development Goals - Resource Centre

Whitmee S., Haines A. et al. (2015) C2

By almost any measure, human health is better now than at any time in history. Life expectancy has soared from 47 years in 1950–1955, to 69 years in 2005–2010, and death rates in children younger than 5 years of age have decreased substantially, from 214 per thousand live births in 1950–1955, ... more

Download (78)

View PDF (868)

Polio

Dattani, S.; F. Spooner, S. Ochmann and M. Roser Our World in Data (2022) CC

Here you can download different charts about cases by world region, prevalence rates, and progress towards polio eradication and much more. Polio is an infectious disease that is caused and transmitted by the poliovirus. Most infections do not lead to any symptoms, but—among the unvaccinated—... more

Download (39)

View PDF (768)

COVID-19 boosters and building trust among UK minority ethnic communities

The Lancet (2022) CC

Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who... more

Download (67)

View PDF (138)

Tuberculosis in Brazil: the impact of the COVID-19 pandemic

Fernandes Maia, C.M.; Barbosa Martelli, D. R.; Mendes L. da Silveira, D. M.; et al. Sociedade Brasileira de Pneumologia e Tisiologia (2022) CC

J Bras Pneumol. 2022;48(2):e20220082 The spread of Severe Acute Respiratory Syndrome - Coronavirus 2 (SARS-CoV-2) continues to progress, causing damage in several countries of the world due to its rapid transmissibility and significant mortality rates, despite government measures to contain its tra... more

Download (57)

View PDF (100)

An integrated, Sustainable Framework to Elimination of Communicable Diseases in the Americas. Concept Note

Pan American Health Organisation (PAHO) (2019) C_WHO

The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou... more

Download (42)

View PDF (242)

Visceral leishmaniasis East Africa

World Health Organization WHO (2023) C_WHO

Visceral leishmaniasis is an important disease in East Africa where recurrent outbreaks occur. Leishmania-HIV coinfected people have high chance of developing the full-blown clinical disease, and high relapse and mortality rates. Poverty, malnutrition and population movements in endemic areas increa... more

Download (201)

View PDF (287)

User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (‎C4P-HPV tool)

World Health Organisation (WHO) (2023) C_WHO

Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin... more

Download (140)

View PDF (102)

Global Accelerated Action for the Health of Adolescents (AA-HA!): guidance to support country implementation, second edition.

World Health Organization WHO (2023) C_WHO

The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respond to the health and well-being challenges, opportunities and needs of adolescents. The guidance pro... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Environmental Health Management After Natural Disaster recommended

State of Health in the WHO African Region recommended

Environmental Health Management After Natural Disaster
recommended

State of Health in the WHO African Region
recommended